SoftOx enters a 6 billion animal health market
Merkur Market-listed SoftOx will revolutionise wound care for animals and estimates a market potential at NOK 6 billion. The company hopes to achieve a double-digit billion turnover in five years.
The medtech Company, SoftOx will enter into a distribution agreement on animal health with VESO, a supplier of vaccines and medicines for animal health. The agreement stipulates that VESO will distribute SoftOx’s new product line, EffectVet for disinfection and wound treatment in the animal health market.